Published on 29 July 2021
Cheshire & Merseyside Cancer Alliance is supporting the delivery of the NHS-Galleri trial.
Galleri™ is a new blood test to detect cancer, often before symptoms appear.
The NHS-Galleri trial is a research trial to see how well the new Galleri™ test works in the NHS when used alongside standard cancer screening.
The aim is to see whether the test can help to find cancers at an early stage when they are easier to treat.
The trial will recruit participants who don’t have any symptoms of cancer or a history of cancer in the last three years.
Many people aged 50-77 in Cheshire and Merseyside will receive an invitation to take part.
The study is in partnership with NHS England and GRAIL and will be run by The Cancer Research UK & King’s College London Cancer Prevention Trials Unit, a team of cancer researchers and trial managers at King’s College London (King’s).
GRAIL Inc. is a company in the United States that developed the Galleri test. They have also set up a branch in the UK, GRAIL Bio UK Ltd (GRAIL) who are the main funder and organiser of this trial.
For more information, visit nhs-galleri.org
